金吾财讯| Hims&Hers Health(HIMS)盘前股价走低，跌5.43%，报38.67美元。消息面上，诺和诺德(NVO)周三表示，将通过一家新的直接面向消费者的在线药房，以每月不到正常价格一半的费用提供其减肥药司美格鲁肽（Wegovy）。Hims去年销售了价值2.25亿美元的Wegovy仿制药，并希望在未来几年将其转变为一个可持续的减肥药业务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.